Because it is still awaiting approval, Medicare does not typically cover the use of ketamine infusion for treating mental ...
The US FDA has approved the first of its kind ketamine-based nasal spray which is supposed to act as a standalone therapy for ...
A ketamine-based nasal spray is officially the first and only standalone therapy available for treatment-resistant depression in the US.
On Tuesday, the US Food and Drug Administration (FDA) approved Johnson & Johnson's hallucinogenic drug esketamine (brand name ...
Here are the top health headlines for the week of Jan. 19, 2025. A nasal spray derived from ketamine gets federal clearance ...